{"id":"W2556430588","doi":"10.1186/s13023-016-0537-5","title":"An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry","year":2016,"lang":"en","type":"review","venue":"Orphanet Journal of Rare Diseases","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"Alexion Pharmaceuticals","keywords":"Medicine; Eculizumab; Alliance; General partnership; Disease; Patient advocacy; Disease registry; Quality of life (healthcare); Intensive care medicine; Family medicine; MEDLINE; Internal medicine; Nursing; Business; Political science; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2364352,0.001036787,0.001088112,0.004897249,0.006346795,0.01195024,0.004509253,0.006428921,0.01725059],"category_scores_gemma":[0.1809658,0.001117505,0.002275654,0.004085124,0.00510841,0.01585893,0.03054609,0.0130373,0.005069018],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00420552,"about_ca_system_score_gemma":0.0729494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001736734,"about_ca_topic_score_gemma":0.003455933,"domain_scores_codex":[0.7424829,0.2207014,0.0102016,0.006723306,0.013542,0.006348845],"domain_scores_gemma":[0.5879329,0.1506442,0.03131508,0.05719227,0.04809375,0.1248218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001024692,0.00149149,0.03763222,0.001733714,0.0004266737,0.002279091,0.01617043,0.001109283,0.002201461,0.04378979,0.4822651,0.409876],"study_design_scores_gemma":[0.0009943576,0.0008505106,0.01048627,0.002474439,0.0001658561,0.001697361,0.009594665,0.001114076,0.0007795544,0.02556955,0.9460651,0.0002082738],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.04089919,0.01517479,0.1012137,0.7362983,0.0229869,0.01232818,0.003616951,0.003128279,0.06435374],"genre_scores_gemma":[0.2801406,0.01413208,0.3697229,0.2351577,0.02586539,0.02563713,0.008678652,0.001821967,0.03884363],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.2364352,"threshold_uncertainty_score":0.9416113,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02835853928980024,"score_gpt":0.3179892136303019,"score_spread":0.2896306743405016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}